Observational studyFrontiers in immunology2022

BNT162b2 Booster Vaccination Elicits Cross-Reactive Immunity Against SARS-CoV-2 Variants B.1.1.529 and B.1.617.2 in Convalescents of All Ages.

Bernd Jahrsdörfer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.